Skip to main content
INSMED Inc logo

INSMED Inc — Investor Relations & Filings

Ticker · INSM ISIN · US4576693075 LEI · 529900Q55QAG41CCAC11 US Manufacturing
Open in API
Filings indexed 1,323 across all filing types
Latest filing 2011-03-02 Share Issue/Capital Cha…
Country US United States of America
Listing US INSM

About INSMED Inc

https://insmed.com/

Insmed Incorporated is a global biopharmaceutical company dedicated to developing and commercializing therapies for patients with serious and rare diseases. The company's primary focus is on addressing areas of high unmet medical need. Its marketed product, Arikayce (liposomal amikacin for inhalation), is a treatment for Mycobacterium avium complex (MAC) lung disease. Insmed leverages proprietary technologies, such as its advanced liposomal pulmonary delivery system, to create novel treatments. The company maintains a diverse pipeline of investigational medicines and is actively advancing potential new therapies through various stages of clinical trials.

Recent filings

Filing Released Lang Actions
8-K Filing
Share Issue/Capital Change Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The content describes a one-for-10 reverse stock split of the company's common stock, effective on March 2, 2011. It includes details about the amendment to the Articles of Incorporation and a press release attached as exhibits. The document does not contain financial statements or detailed financial analysis but rather announces a capital structure change. According to the filing definitions, announcements regarding stock splits or other capital changes fall under 'Share Issue/Capital Change' (SHA). The document length is under 5,000 characters and is a direct announcement, not a report publication notice or certification. Therefore, the correct classification is SHA with high confidence.
2011-03-02 English
8-K Filing
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content focuses on the submission of matters to a vote of security holders, specifically the approval of conversion of preferred stock and a reverse stock split, including detailed voting results. It also mentions the intention to file an amendment to effect the reverse stock split. There is no detailed financial data or comprehensive financial statements, so it is not an Annual Report (10-K) or Interim Report (IR). The document is not a proxy solicitation or presentation but a report of voting results and corporate actions. The closest fitting category is Declaration of Voting Results & Voting Rights Announcements (DVA), as it reports official shareholder vote outcomes and related corporate actions. The document length (6076 characters) and detailed vote counts support this classification with high confidence.
2011-03-01 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement with Chiltern International Inc. for clinical services, details about the agreement terms, and references to a proxy statement for shareholder approval of stock conversion and reverse stock split. There are no financial statements or detailed financial performance data present, so it is not an Annual Report (10-K) or Interim Report (IR). It is not a proxy solicitation itself but references a proxy statement filed earlier. The document is primarily an announcement of a material contract and related corporate actions, typical of a Regulatory Filing (RNS). The length (8277 characters) and detailed content confirm it is not a brief announcement or a certification. Therefore, the best classification is Regulatory Filings (RNS).
2011-02-17 English
4 Filing
Director's Dealing
2011-02-01 English
4 Filing
Director's Dealing
2011-02-01 English
4 Filing
Director's Dealing
2011-02-01 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.